CrushSCI.com
Journal Selection & Manuscript Polishing Services
HUMAN PATHOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

HUMAN PATHOLOGY

Elsevier SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
69.1Average days
65Median days
24Fastest days
149Longest days
2052025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

84 days

Single-section assessment of DNA mismatch repair using PMS2/MSH6 double immunohistochemistry

AuthorsYuichiro Hatano; Kohei Taniguchi; Akihiko Toji; Shinichi Terada; Hiroki Hamamoto; Tomohito Tanaka; Sang-Woong Lee; Yoshinobu Hirose

AffiliationsDepartment of Pathology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569‐8686, Japan; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569‐8686, Japan; Department of Obstetrics and Gynecology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569‐8686, Japan; Department of General and Gastroenterological Surgery, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569‐8686, Japan

Source PDF DOI Publisher page
90 days

Metastatic pancreatic acinar cell carcinoma to the liver mimicking neuroendocrine tumor (NET) and pancreatic ductal adenocarcinoma (PDAC): A series of seven cases

AuthorsTiane Chen; Ralph H. Hruban; Pedram Argani

AffiliationsDepartments of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Departments of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Source PDF DOI Publisher page
70 days

Clinicopathologic and histologic determinants of the oncotype DX recurrence score in ER+/HER2− breast cancer: AJCC stage-matched comparisons and predictors of a very low recurrence score

AuthorsZohre Sadeghian; Sara Rhode; Hadi Sultan; Theresa Abdo; Ahmad Alhalabi; Elvia Goez-Gutierrez; Zeina Nahleh; Esther Yoon

AffiliationsDepartment of Pathology & Laboratory Medicine, Cleveland Clinic Florida, Weston, FL, USA; Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA; Department of Hematology and Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, USA

Source PDF DOI Publisher page
44 days

Clinicopathologic and molecular characteristics of acral melanomas harboring RARA fusions

AuthorsMokhtar H. Abdelhammed; Richard K. Yang; Volha Lenskaya; Carlos A. Torres-Cabala; Woo Cheal Cho

AffiliationsDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Source PDF DOI Publisher page
60 days

Clinical impact of second opinion consultation in bladder biopsies and transurethral resection of bladder tumors

AuthorsCarla Calagua; Swati Bhardwaj; Veronica Ochoa Cholan; Mahsa Hojabri; Andres Matoso

AffiliationsDepartment of Pathology, United States; Oncology, United States; Urology, The Johns Hopkins Hospital, Baltimore, MD, United States; Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD, United States

Source PDF DOI Publisher page
74 days

TRPS1 and GATA3 expression in BRG1/SMARCA4-deficient malignant neoplasms

AuthorsJing Han; Yang Ding; Qiong Gan; Keith Sweeney; Xiao Huang; Nadia Hameed; Annikka Weissferdt; Yaohong Wang; Yan Peng; Hongxia Sun

AffiliationsDepartment of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA

Source PDF DOI Publisher page
24 days

Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors

AuthorsAntonin Fattori; Xiaofan Lu; Philippe Baltzinger; Philippe Bachellier; Pietro Addeo; Alessio Imperiale; Patrick Pessaux; Jean-Emmanuel Kurtz; Bernard Goichot; Thomas F. Baumert; Marie-Pierrette Chenard; Gabriel G. Malouf

AffiliationsDepartment of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France; Department of Pathology, Strasbourg University Hospitals, Strasbourg, France; Department of Endocrinology, Diabetology and Nutrition, Strasbourg University Hospitals, Strasbourg, France; Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Strasbourg University Hospitals, Strasbourg, France; Department of Nuclear Medicine, Strasbourg University Hospitals, Strasbourg, France; Department of Digestive and Endocrine Surgery, Strasbourg University Hospitals, Strasbourg, France; Department of Medical Oncology, Strasbourg University Hospitals, Strasbourg, France; University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_1110, Strasbourg, France; Gastroenterology and Hepatology Service, Strasbourg University Hospitals, Strasbourg, France; IHU Strasbourg, Strasbourg, France; Institut Universitaire de France, Paris, France

Source PDF DOI Publisher page
149 days

Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow

AuthorsRyutaro Onaga; Shingo Sakashita; Daisuke Komura; Nobuyuki Nakamura; Makoto Tahara; Genichiro Ishii; Tohru Ikeda; Shumpei Ishikawa

AffiliationsDepartment of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Department of Otolaryngology and Head and Neck Surgery, Jichi Medical University, Tochigi, Japan; Department of Clinical Oncology, Jichi Medical University, Tochigi, Japan; Division of Pathology, National Cancer Center, Exploratory Oncology Research & Clinical Trial Center, Kashiwa, Japan; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Department of Preventive Medicine, The University of Tokyo, Tokyo, Japan; Department of Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Department of Oral Pathology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan

Source PDF DOI Publisher page
36 days

Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma: Evaluating primary vs. secondary myeloid sarcoma

AuthorsChristine W. Kahlow; Sharon Germans; Maximiliano Ramia de Cap; Adam Bagg; Wei Du; Stephanie Hurwitz; Daniel A. Arber; Andrew Hermina; Falko Fend; Dominik Nann; Weina Chen; Mingyi Chen; Miguel D. Cantu; Wayne Tam; Carlos R. Bueso-Ramos; Rashmi Kanagal-Shamanna; Philipp W. Raess; Alexa Siddon; Tracy I. George; Kathryn Foucar; Robert P. Hasserjian; Olga K. Weinberg

AffiliationsDepartment of Hematopathology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Imperial College Healthcare NHS Trust, London, UK; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology, The University of Chicago, Chicago, IL, USA; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA; Department of Pathology, Yale School of Medicine, New Haven, CT, USA; ARUP Laboratories, Salt Lake City, UT, USA; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA; Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA; Department of Pathology, Harvard Medical School, Boston, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA

Source PDF DOI Publisher page
60 days

The Farooq, not the Lerner, grading system predicts disease-specific and overall survival in duodenal graft-versus-host disease

AuthorsBei Yang; Reem Youssef; Omer Saeed; Iván A. González

AffiliationsDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.